(Q46797974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Leishmania major

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Eltahir Khalil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

I N Satti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Y Osman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S A Younis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E E Zijlstra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A M El Hassan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H W Ghalib

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

15-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

2100-2106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

Studies on the leishmaniases in the Sudan. 1. Epidemic of cutaneous leishmaniasis in Khartoum

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Identification of Leishmania from mucosal leishmaniasis by recombinant DNA probes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Experiences with vaccines against cutaneous leishmaniasis: of men and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Responses to Montenegro antigen after immunization with killed Leishmania promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

A field trial of a vaccine against American dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Further trials of a vaccine against American cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: antibody responses to mycobacterial and leishmanial antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Editorial: Measurement of delayed skin-test responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

The immunobiology of leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Prevalence of cutaneous leishmaniasis along the Nile River north of Khartoum (Sudan) in the aftermath of an epidemic in 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

T-cell and cytokine responses in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900401-1

7 January 2021

10.1016/S0264-410X(00)00401-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228382%20AND%20SRC:MED&resulttype=core&format=json

release_7s7x2ew2fnhwja3tylkllvbbji

5 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7s7x2ew2fnhwja3tylkllvbbji

24 November 2022

mapped directly with Wikidata item

1 reference